USP32 Facilitates Non-Small Cell Lung Cancer Progression via Deubiquitinating BAG3 and Activating RAF-MEK-ERK Signaling Pathway

Interference with ubiquitin-specific peptidase 32 (USP32) resulted in a significant inhibition of NSCLC cell proliferation, migration potential, and EMT development; on the other hand, USP32 overexpression had the opposite effect.